Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer

Genetic profiling of urine cell free DNA (cfDNA) has not been evaluated in advanced prostate cancer. We performed whole genome sequencing of urine cfDNAs to identify tumor-associated copy number variations in urine before and after initiating androgen deprivation therapy in HSPC stage and docetaxel...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Xia, Yun, Huang, Chiang-Ching, Dittmar, Rachel, Du, Meijun, Wang, Yuan, Liu, Hongyan, Shenoy, Niraj, Wang, Liang, Kohli, Manish
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094965/
https://ncbi.nlm.nih.gov/pubmed/27127882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9027
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller